Literature DB >> 30950912

PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Tyler Stevens1, Katrin Sangkuhl2, Jacob T Brown3, Russ B Altman2,4,5,6, Teri E Klein2,6.   

Abstract

Entities:  

Year:  2019        PMID： 30950912      PMCID： PMC6581573          DOI： 10.1097/FPC.0000000000000376

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  231 in total

1.  The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats.

Authors:  Kathryn E Gill; Thomas J R Beveridge; Hilary R Smith; Linda J Porrino
Journal:  Brain Res       Date:  2013-06-24       Impact factor: 3.252

2.  Effect of preexposure on methylphenidate-induced taste avoidance and related BDNF/TrkB activity in the insular cortex of the rat.

Authors:  B Bradley Wetzell; Mirabella M Muller; Shaun M Flax; Heather E King; Kathleen DeCicco-Skinner; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

3.  Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.

Authors:  B Prieto-Gómez; A M Vázquez-Alvarez; J L Martínez-Peña; C Reyes-Vázquez; P B Yang; N Dafny
Journal:  Life Sci       Date:  2005-06-24       Impact factor: 5.037

4.  Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.

Authors:  R M Ferris; F L Tang
Journal:  J Pharmacol Exp Ther       Date:  1979-09       Impact factor: 4.030

5.  Lack of association between the tryptophan hydroxylase gene A218C polymorphism and attention-deficit hyperactivity disorder in Chinese Han population.

Authors:  G Tang; D Ren; R Xin; Y Qian; D Wang; S Jiang
Journal:  Am J Med Genet       Date:  2001-08-08

6.  The metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorder.

Authors:  Subin Park; Bung-Nyun Kim; Soo-Churl Cho; Jae-Won Kim; Johanna Inhyang Kim; Min-Sup Shin; Hee-Jeong Yoo; Doug Hyun Han; Jae Hoon Cheong
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

7.  ABCB1 c.2677G>T variation is associated with adverse reactions of OROS-methylphenidate in children and adolescents with ADHD.

Authors:  So Won Kim; Ji Hyun Lee; Sung Hee Lee; Hyun Ju Hong; Min Goo Lee; Ki-Hwan Yook
Journal:  J Clin Psychopharmacol       Date:  2013-08       Impact factor: 3.153

8.  Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor.

Authors:  Russell W Brown; Benjamin A Hughes; Andrew B Hughes; A Brianna Sheppard; Marla K Perna; W Lee Ragsdale; Ross L Roeding; Brooks B Pond
Journal:  J Psychopharmacol       Date:  2012-07-24       Impact factor: 4.153

9.  Methylphenidate significantly alters the functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area.

Authors:  Ike C Dela Peña; Guofang Shen; Wei-Xing Shi
Journal:  Neuropharmacology       Date:  2018-01-13       Impact factor: 5.250

10.  Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.

Authors:  Chun-Lei Zhang; Ze-Jun Feng; Yue Liu; Xiao-Hua Ji; Ji-Yun Peng; Xue-Han Zhang; Xue-Chu Zhen; Bao-Ming Li
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
View more
  1 in total

Review 1.  Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.

Authors:  Rafał R Jaeschke; Ewelina Sujkowska; Magdalena Sowa-Kućma
Journal:  Psychopharmacology (Berl)       Date:  2021-08-26       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.